IONS vs REPL
Ionis Pharmaceuticals Inc (IONS) versus Replimune Group Inc (REPL) — a side-by-side from cached financials, not a winner call.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Replimune Group Inc (REPL) is a biotechnology company listed on NASDAQ.
Latest reported IONS revenue for 2024-12-31 was $226.6M. Net income was -$104.3M. Revenue was down 30.2% from 2023-12-31 to 2024-12-31. IONS currently screens at market cap $12.28B.
REPL does not have a complete income-statement cache yet.
IONS currently screens at market cap $12.28B. REPL currently screens at market cap $825.7M.
Not investment advice. Open the IONS and REPL stock pages for the full models.
Not investment advice.